Literature DB >> 31700890

Identification of CD2, CCL5 and CCR5 as potential therapeutic target genes for renal interstitial fibrosis.

Chuanjie Zhang1, Xin Hu2, Feng Qi3, Jun Luo4, Xiao Li5.   

Abstract

BACKGROUND: We aimed to explore potential gene biomarkers of renal interstitial fibrosis (RIF) due to a lack of effective and non-invasive methods for diagnosis.
METHODS: Three data sets (GSE22459, GSE76882 and GSE57731) including 350 samples were acquired from Gene Expression Omnibus (GEO) database. We used bioconductor limma package to perform background adjustment. Cluster analysis was conducted by 'edgeR' package to identify the differentially expressed genes (DEGs). We generated heat maps with using heatmap package in R software. Function annotation of genes was performed by Gene Ontology (GO) enrichment analysis. STRING (Search Tool for the Retrieval of Interacting Genes) database was employed to construct the protein-protein interaction (PPI) network and the results were visualized by Cytoscape 3.6.1. At last, we applied Graphpad Prism 7.0. to explore the correlation between three hub genes and pathological degrees of RIF.
RESULTS: By applying the "edgeR" package in R, we detected 116 DEGs with three data sets. These genes were enriched in 19 GO biological process categories. Three main hub genes (CD2, CCL5 and CCR5) were identified after construction of PPI network. In Pearson correlation coefficient, CD2, CCL5 and CCR5 was found to hold higher expression patterns in RIF samples based on independent data set GSE57731. Besides, their gene expression levels were found significantly positive correlation with the degree of RIF (CD2: P<0.05, r=0.29; CCL5: P<0.05, r=0.31; CCR5: P<0.05, r=0.38).
CONCLUSIONS: CD2, CCL5 and CCR5 might serve as potential early biomarkers of RIF. The mechanism between these genes and RIF remains to be further studied. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Gene Expression Omnibus (GEO); Renal transplantation; diagnosis; gene; renal interstitial fibrosis (RIF)

Year:  2019        PMID: 31700890      PMCID: PMC6803237          DOI: 10.21037/atm.2019.08.62

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  37 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.

Authors:  J Sellarés; D G de Freitas; M Mengel; J Reeve; G Einecke; B Sis; L G Hidalgo; K Famulski; A Matas; P F Halloran
Journal:  Am J Transplant       Date:  2011-11-14       Impact factor: 8.086

Review 3.  Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis.

Authors:  Ana S Cruz-Solbes; Keith Youker
Journal:  Results Probl Cell Differ       Date:  2017

4.  Long-term renal allograft survival in the United States: a critical reappraisal.

Authors:  K E Lamb; S Lodhi; H-U Meier-Kriesche
Journal:  Am J Transplant       Date:  2010-10-25       Impact factor: 8.086

5.  Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases.

Authors:  Marios Papasotiriou; Federica Genovese; Barbara M Klinkhammer; Uta Kunter; Signe H Nielsen; Morten A Karsdal; Jürgen Floege; Peter Boor
Journal:  Nephrol Dial Transplant       Date:  2015-03-16       Impact factor: 5.992

6.  Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy.

Authors:  Holger Schmid; Anissa Boucherot; Yoshinari Yasuda; Anna Henger; Bodo Brunner; Felix Eichinger; Almut Nitsche; Eva Kiss; Markus Bleich; Hermann-Josef Gröne; Peter J Nelson; Detlef Schlöndorff; Clemens D Cohen; Matthias Kretzler
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

7.  CD4+ T Lymphocytes, especially Th2 cells, contribute to the progress of renal fibrosis.

Authors:  Lili Liu; Pei Kou; Qiao Zeng; Guangchang Pei; Yueqiang Li; Huifang Liang; Gang Xu; Sheng Chen
Journal:  Am J Nephrol       Date:  2012-10-09       Impact factor: 3.754

8.  TGF-β-mediated upregulation of Sox9 in fibroblast promotes renal fibrosis.

Authors:  Huanan Li; Huimin Cai; Jia Deng; Xiaolong Tu; Yanyan Sun; Zhen Huang; Zhi Ding; Lei Dong; Jiangning Chen; Yuhui Zang; Junfeng Zhang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-11-21       Impact factor: 5.187

9.  Living-donor transplantation leads to a major improvement in physical functioning: an observational study on the impact on potential donors and their recipients.

Authors:  Natascha J H Broers; Tsz Yeung Fung; Jeroen P Kooman; Maarten H L Christiaans
Journal:  BMC Nephrol       Date:  2019-03-29       Impact factor: 2.388

10.  Regulatory T-cell Number in Peripheral Blood at 1 Year Posttransplant as Predictor of Long-term Kidney Graft Survival.

Authors:  David San Segundo; Luis H Galván-Espinoza; Emilio Rodrigo; Juan Irure; Juan C Ruiz; Gema Fernández-Fresnedo; Laura Riesco; Jairo Bada; Lara Belmar; Marcos Lopez-Hoyos
Journal:  Transplant Direct       Date:  2019-02-08
View more
  2 in total

1.  CCL5 Suppresses Klotho Expression via p-STAT3/DNA Methyltransferase1-Mediated Promoter Hypermethylation.

Authors:  QiFeng Liu; ShaSha Li; LiXia Yu; XiaoYa Yin; Xi Liu; JianMing Ye; GuoYuan Lu
Journal:  Front Physiol       Date:  2022-03-01       Impact factor: 4.566

2.  Identification of key biomarkers and immune infiltration in renal interstitial fibrosis.

Authors:  Zhanhong Hu; Yumei Liu; Ye Zhu; Hongxia Cui; Jie Pan
Journal:  Ann Transl Med       Date:  2022-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.